BackMerrimack Pharmaceuticals Overview

Merrimack Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for MACK.

Quarterly Other Income/Expense

$233000.00
↑ 32.39% YoY

As of Mar 31, 2024

Annual Other Income/Expense (TTM)

$925000.00
↑ 154.12% YoY

Trailing 12 months ending Mar 31, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin